{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:45:20Z","timestamp":1779129920156,"version":"3.51.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02004","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T06:22:38Z","timestamp":1597126958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?"],"prefix":"10.3389","volume":"11","author":[{"given":"Kissy","family":"Guevara-Hoyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Ochoa-Grull\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Fern\u00e1ndez-Arquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacruz","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"P\u00e9rez de Diego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency.","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders.","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","article-title":"Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts.","volume":"130","author":"Chapel","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0090-1229(90)90145-g","article-title":"Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2.","volume":"56","author":"Bryant","year":"1990","journal-title":"Clin Immunol Immunopathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/0004563213518758","article-title":"Serum-free light-chain assay: clinical utility and limitations.","volume":"51","author":"Bhole","year":"2014","journal-title":"Ann Clin Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jaci.2014.10.003","article-title":"Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia.","volume":"135","author":"Compagno","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00319","article-title":"Serum free light chains in common variable immunodeficiency disorders: role in differential diagnosis and association with clinical phenotype.","volume":"11","author":"Scarpa","year":"2020","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/jclinpath-2012-201044","article-title":"Abnormalities of serum-free light chain in patients with primary antibody deficiency in the absence of B lymphocyte clonality.","volume":"65","author":"Unsworth","year":"2012","journal-title":"J Clin Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1098\/rspl.1899.0121","article-title":"Croonian lecture.\u2013on immunity with special reference to cell life.","volume":"66","author":"Ehrlich","year":"1900","journal-title":"Proc R Soc London."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins.","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.medcli.2011.11.022","article-title":"Inmunoglobulinas intravenosas: llave inmunomoduladora del sistema inmunol\u00f3gico.","volume":"139","author":"Ramos-Medina","year":"2012","journal-title":"Med Cl\u00edn."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02423","article-title":"The role of the Pre-B cell receptor in B cell development, repertoire selection, and tolerance.","volume":"9","author":"Winkler","year":"2018","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood-2003-12-4359","article-title":"Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency.","volume":"105","author":"Andersen","year":"2005","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/gene.2012.12","article-title":"The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease.","volume":"13","author":"Watson","year":"2012","journal-title":"Genes Immunity."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1043\/1543-2165-134.6.e40","article-title":"Protocol for the examination of specimens from patients with non-hodgkin lymphoma\/lymphoid neoplasms.","volume":"134","author":"Hussong","year":"2010","journal-title":"Arch Pathol Lab Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1200\/JCO.2010.29.4413","article-title":"Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.","volume":"29","author":"Maurer","year":"2011","journal-title":"J Clin Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2009.25.1322","article-title":"Circulating serum free light chains as predictive markers of AIDS-related lymphoma.","volume":"28","author":"Landgren","year":"2010","journal-title":"J Clin Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/leu.2012.100","article-title":"Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.","volume":"26","author":"Comenzo","year":"2012","journal-title":"Leukemia."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040842","article-title":"The impact of immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation.","volume":"9","author":"Konen","year":"2020","journal-title":"Cells."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203392","article-title":"Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA\/GEM phase III clinical trials.","volume":"13","author":"Lopez-Anglada","year":"2018","journal-title":"PLoS One."},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14737159.2019.1586535","article-title":"Diagnostic utility of kappa free light chains in multiple sclerosis.","volume":"19","author":"Kaplan","year":"2019","journal-title":"Expert Rev Mol Diagn."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040804","article-title":"Analytical criticalities associated to different immunological methods for serum free light chain detection in plasma cell dyscrasias: a description of particular clinical cases.","volume":"18","author":"Sabatino","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-019-0220-x","article-title":"Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.","volume":"9","author":"Clay-Gilmour","year":"2019","journal-title":"Blood Cancer J."},{"key":"B26","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1182\/blood-2011-04-345587","article-title":"The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.","volume":"118","author":"Morabito","year":"2011","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.leukres.2014.09.006","article-title":"The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma.","volume":"38","author":"Han","year":"2014","journal-title":"Leuk Res."},{"key":"B28","year":"","journal-title":"Registry Working Party Diagnosis criteria."},{"key":"B29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10875-018-0478-y","article-title":"Serum free light chains in CVID-a marker for differential diagnosis.","volume":"38","author":"Hanitsch","year":"2018","journal-title":"J Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108307","article-title":"Evaluation of polysaccharide typhim Vi antibody response as a predictor of humoral immunodeficiency in haematological malignancies.","volume":"210","author":"Ochoa-Grull\u00f3n","year":"2020","journal-title":"Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejmg.2016.02.003","article-title":"Immunoglobulin K light chain deficiency: a rare, but probably underestimated, humoral immune defect.","volume":"59","author":"Sala","year":"2016","journal-title":"Eur J Med Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies.","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.187.1.71","article-title":"Mutations in the human lambda5\/14.1 gene result in B cell deficiency and agammaglobulinemia.","volume":"187","author":"Minegishi","year":"1998","journal-title":"J Exp Med."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02912","article-title":"Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an interdisciplinary working group.","volume":"9","author":"Bomken","year":"2018","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives.","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03136","article-title":"Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework.","volume":"9","author":"Haas","year":"2019","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry.","volume":"141","author":"Mayor","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-198805001-00003","article-title":"Relationship of immunodeficiency to lymphoid malignancy.","volume":"7","author":"Kersey","year":"1988","journal-title":"Pediatr Infect Dis J."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00777","article-title":"A Systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (Inborn Errors of Immunity).","volume":"10","author":"Riaz","year":"2019","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2012-05-431064","article-title":"Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency.","volume":"120","author":"Quinti","year":"2012","journal-title":"Blood."},{"key":"B41","first-page":"79","article-title":"Malignancies as the main cause of death in common variable immunodeficiency: an italian multicentre study.","volume":"3","author":"Pulvirenti","year":"2018","journal-title":"Eur Med J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.leukres.2015.02.002","article-title":"Lymphoproliferative disease and cancer among patients with common variable immunodeficiency.","volume":"39","author":"Gangemi","year":"2015","journal-title":"Leuk Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14740\/jocmr2802w","article-title":"Serum free light chain assay and \u03ba\/\u03bb ratio: performance in patients with monoclonal gammopathy-high false negative rate for \u03ba\/\u03bb ratio.","volume":"9","author":"Singh","year":"2017","journal-title":"J Clin Med Res."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020451","article-title":"Common variable immunodeficiency and gastric malignancies.","volume":"19","author":"Leone","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.4049\/jimmunol.175.8.5498","article-title":"Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients.","volume":"175","author":"Taubenheim","year":"2005","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02249","article-title":"Immunoglobulin light chain gene rearrangements, receptor editing and the development of a self-tolerant antibody repertoire.","volume":"9","author":"Collins","year":"2018","journal-title":"Front Immunol."},{"key":"B47","article-title":"Immunoglobulin gene construction: human.","author":"Lucas","year":"","journal-title":"eLS."},{"key":"B48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2567.2000.00151.x","article-title":"Role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.","volume":"101","author":"M\u00e5rtensson","year":"2000","journal-title":"Immunology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1084\/jem.177.4.999","article-title":"Receptor editing: an approach by autoreactive B cells to escape tolerance.","volume":"177","author":"Gay","year":"1993","journal-title":"J Exp Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/s0092-8674(02)00675-x","article-title":"The mechanism and regulation of chromosomal V(D)J recombination.","author":"Bassing","year":"2002","journal-title":"Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1101\/gad.13.10.1246","article-title":"Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma.","volume":"13","author":"Liao","year":"1999","journal-title":"Genes Dev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency.","volume":"124","author":"Yu","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaci.2016.04.043","article-title":"Disturbed canonical nuclear factor of \u03ba light chain signaling in B cells of patients with common variable immunodeficiency.","volume":"139","author":"Keller","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.4049\/jimmunol.1402690","article-title":"TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.","volume":"194","author":"Simchoni","year":"2015","journal-title":"J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.1073\/pnas.95.22.13135","article-title":"Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome.","volume":"95","author":"Levy","year":"1998","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T06:22:42Z","timestamp":1597126962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2020.02004"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02004","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"2004"}}